Check our latest news and where we are going to be soon.
Biohope Receives an Honorary Plaque from the Spanish Association of Scientists in Recognition of Its Work in Developing Precision Medicine Diagnostic Tools
Biohope Receives an Honorary Plaque from the Spanish Association of Scientists in Recognition of Its Work in Developing Precision Medicine Diagnostic Tools Madrid, November 25th, 2024. The Spanish Association of Scientists held the XXVI Edition of the [...]
Spanish biotech Biohope develops a first in class device to personalize the first line of treatment for rheumatoid arthritis
The Community of Madrid grants the company, which received the Seal of Excellence of the European Innovation Council's Accelerator program, a grant of two million euros to carry out the project The economic burden of rheumatoid arthritis [...]
Biohope is awarded for its innovation by the European Investment Bank (EIB)
At the ‘EIB AdVenture Debt Summit’, Biohope received one of the ‘Innovation Champion Awards’ from the European Investment Bank (EIB) for its development of innovative projects in the field of precision medicine. Isabel Portero, CEO and founder [...]
Biohope Shines at SET2024 Congress in Bilbao
Following the recent Congress of the Spanish Society of Transplantation (SET) in Bilbao, the organization has published the latest edition of SETnews. This issue summarizes the scientific sessions of the 8th SET Congress 2024, highlighting a [...]
Biohope Welcomes Nuria de Pedro as R&D Director
Biohope is delighted to announce the appointment of Nuria de Pedro, PhD, as the new Research and Development (R&D) Director. With 25 years of extensive experience in the pharmaceutical and biotech industries, she brings a wealth of [...]
Pilar Najarro joins Biohope as Managing Director
Biohope is thrilled to announce the latest addition to our dynamic team. Dr. Pilar Najarro, a distinguished professional with a rich background in Health and Biotech, has joined us as Managing Director. Pilar's journey in the field [...]
Isabel Portero presents Immunobiogram for Renal Transplant at the 3rd edition of “Future of Transplantation meeting” organized by AST in Boston
Our CEO, Isabel Portero, took stage at the 3rd edition of the "Future of Transplantation Meeting" organized by the American Society of Transplantation (AST) in Boston, where she presented the groundbreaking Immunobiogram for Renal Transplant. Dedicated [...]
Results from IMBITRA clinical study have been presented at the 53rd SEN Congress 2023
Results from IMBITRA study of Immunobiogram in renal transplant patients in maintenance phase have been presented at the 53rd SEN Congress 2023, which took place in Palma de Mallorca on November 11th - 13th. IMBITRA study [...]
Biohope Receives CDTI Grant for Development of In Vitro Test to Monitor Autoimmune Diseases
Biohope, a leading company in personalized medicine, has been awarded a grant by the Center for the Development of Industrial Technology (CDTI) to support its project titled "Development of a Cellular Assay for Monitoring Autoimmune Diseases" (Project [...]
Biohope presents results of novel IVD solution in Rheumatoid Arthritis at EULAR Congress 2023
Biohope has presented a poster with clinical study results of the novel ROS and Monocytes tests to measure in vitro the methotrexate response in early rheumatoid arthritis patients at the European Congress of Rheumatology 2023 (EULAR), [...]
